- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Substandard Azithromycin: Andhra spurious drugs investigation leads DCA to Chandigarh in search of wholesaler
Amaravati: Following the detection of substandard Azithromycin antibiotics in Andhra Pradesh recently, the state's Drugs Control Administration (DCA) has dispatched a team of officials to Chandigarh as the wholesaler who supplied those drugs are located there.
"The substandard drugs we received came through a wholesaler located in Chandigarh. So the investigation is happening in Chandigarh now," a DCA official told IANS on Monday.
The team has been fortified with the addition of an inspector from the Drugs Controller General of India (DGCI) and also officials from the relevant drugs control department in Punjab.
"After completing its probe in Chandigarh, the team will visit Uttarakhand as well," the official said, as the manufacturer is believed to be located there.
Meanwhile, the DCA conducted an awareness programme for medicine wholesalers in all the 13 districts of the southern state on Monday.
In each district, the DCA assistant director and his team members conducted the programme to educate the wholesalers as to where they are procuring the medicines from and if the sellers had a licence.
"We told them that they have to check if the product has a licence and the company has a licence. The wholesale buyers have to verify all these details and only then they should buy the medicines," said the official.
The official shared two phone numbers, 0863-2330909 and 0863-2339246, to call and alert the department if they stumble upon spurious drugs. An email address has also been provided for the purpose -- dca-grams@ap.gov.in.
Recently, the DCA seized different strengths and combinations of substandard manufactured antibiotic Azithromycin from Rajahmundry, Bhimavaram and Vijayawada, prompting the department to launch a hunt to identify the culprits and nip the crime in the bud.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751